Latest Oxbryta Lawsuit Updates
As of November 2025, there is no large-scale litigation surrounding Oxbryta. However, as more patients and their families file lawsuits against Pfizer, there’s growing talk about a possible multidistrict litigation. Here’s a look at some of the most recent lawsuit developments:
Free Oxbryta Lawsuit Case Review
Preparing Case Review Form. ConsumerShield is transforming the way consumers experience law.
-
One relatively high-profile Oxbryta lawsuit involves a man who suffered a blood clot and a stroke. In October 2025, he reached a possible settlement with Pfizer. However, the settlement hasn’t been finalized, and the settlement amount hasn’t been made public.
-
Because Oxbryta was recalled relatively recently, patients are still finding out that their blood clots, strokes and other complications may have been caused by Oxbryta.
Currently, lawsuits are scattered across the country, so it can be difficult to determine how many have been filed. Court documents indicate that there are at least 18 pending Oxbryta lawsuits, though.
-
Many Oxbryta lawsuits are filed by plaintiffs who have suffered serious side effects, but the medication has also been linked to deaths in some patients. One woman filed a wrongful death lawsuit against Pfizer after her husband died from what was believed to be an Oxybryta-induced stroke.
-
Most lawsuits involving dangerous drugs hold defendants strictly liable for damages. This means that plaintiffs don’t have to prove the defendant was negligent; instead, they just need to prove that the drug caused them harm.
One Oxbryta lawsuit filed in November 2024 stands out because it alleges that Pfizer acted recklessly. Specifically, it claimed that the company was aware of serious safety concerns but made an effort to hide these concerns from the public.
Oxbryta Lawsuit Knowledge Base
Read the latest information on Oxbryta Lawsuit and find answers to your questions. Currently there are 3 topics about Oxbryta Lawsuit Lawsuits.
Updates
Settlements & Payouts